Please Wait.....
Report
United Kingdom Monkeypox Therapeutics Market, By Treatment (Smallpox Vaccine, Antivirals, Vaccinia Immune Globulin (VIG)), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027
Market Report I 2022-08-01 I 72 Pages I TechSci Research
The United Kingdom monkeypox therapeutics market is projected to register growth at a formidable rate during the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of monkeypox in the country and expanding population with weak immunity.
Monkeypox is a virus with a rapid pace of dissemination. According to the World Health Organization, the illness has a 3-6% death rate and causes fever, excruciating headaches, swollen lymph nodes, and other symptoms (WHO). Through close contact with respiratory secretions and skin lesions, the disease can be transferred from one person to another. Generally, prolonged face-to-face contact is necessary for the transmission of respiratory droplet particles, putting health workers, household members, and other close contacts of active cases at risk.
The rapid spread of monkeypox is boosting the market's growth by driving the demand for emergency medications for timely and efficient treatment. Additionally, researchers around the United Kingdom are constantly working to create pharmaceuticals in large quantities so that more patients can avail them. To enable the development of new drugs to stop the spread of monkeypox around the world, research and development operations need to make significant expenditures on cutting-edge machinery and technologies.
Some of the primary growth-inducing elements for the monkeypox treatments market are the expanding infrastructure and the simple accessibility to healthcare facilities. The United Kingdom provides its residents with modern, state-of-the-art healthcare facilities that raise awareness of a variety of disorders. Additionally, the necessity to get tested if experiencing any symptoms is driven by the public's growing knowledge of the monkeypox virus. This increases the need for hospitals or clinics to provide quality medical care.
The United Kingdom monkeypox therapeutics market is segmented on the basis of treatment, end user, regional distribution, and competitive landscape. Based on end user, the market is divided into hospitals, specialty clinics, ambulatory surgical centers, and others. The hospital segment is anticipated to dominate the United Kingdom monkeypox therapeutics market, owing to the increasing number of patients getting admitted to the hospital to seek treatment for the virus rather than in other healthcare systems.
Major players operating in the United Kingdom monkey therapeutics market are Chimerix UK Limited, SIGA Technologies, Inc., Emergent BioSolutions UK Ltd., Bavarian Nordic A/S, Mylan N.V., Olon S.p.A., Teva UK Limited, among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth in the market size of the United Kingdom monkeypox therapeutics from 2017 to 2021.
- To estimate and forecast the market size of United Kingdom monkeypox therapeutics market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the United Kingdom monkeypox therapeutics market based on treatment, end user, region, and company.
- To identify the dominant region or segment in the United Kingdom monkeypox therapeutics market.
- To identify drivers and challenges for the United Kingdom monkeypox therapeutics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the United Kingdom monkeypox therapeutics market.
- To identify and analyze the profiles of leading players operating in the United Kingdom monkeypox therapeutics market.
- To identify key sustainable strategies adopted by market players in United Kingdom monkeypox therapeutics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers and presence of all major players across the country.
TechSci Research calculated the market size of the United Kingdom monkeypox therapeutics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, United Kingdom monkeypox therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- United Kingdom Monkeypox Therapeutics Market, By Treatment:
o Smallpox Vaccine
o Antivirals
o Vaccinia Immune Globulin (VIG)
- United Kingdom Monkeypox Therapeutics Market, By End User:
o Hospitals
o Specialty Clinics
o Ambulatory Surgical Centers
o Others
- United Kingdom Monkeypox Therapeutics Market, By Region:
o London
o Southeast
o East Anglia
o Scotland
o Southwest
o East Midlands
o Yorkshire & Humberside
o Rest of United Kingdom
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United Kingdom monkeypox therapeutics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
o Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United Kingdom Monkeypox Therapeutics Market
4. Executive Summary
5. Voice of Customer
6. United Kingdom Monkeypox Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment (Smallpox Vaccine, Antivirals, Vaccinia Immune Globulin (VIG))
6.2.2. By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others)
6.2.3. By Region
6.2.4. By Company (2021)
6.3. Product Market Map
7. London Monkeypox Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment
7.2.2. By End User
8. East Anglia Monkeypox Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment
8.2.2. By End User
9. Southwest Monkeypox Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment
9.2.2. By End User
10. Southeast Monkeypox Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment
10.2.2. By End User
11. Scotland Monkeypox Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Treatment
11.2.2. By End User
12. East Midlands Monkeypox Therapeutics Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Treatment
12.2.2. By End User
13. Yorkshire & Humberside Monkeypox Therapeutics Market Outlook
13.1. Market Size & Forecast
13.1.1. By Value
13.2. Market Share & Forecast
13.2.1. By Treatment
13.2.2. By End User
14. Market Dynamics
14.1. Drivers
14.2. Challenges
15. Market Trends & Developments
16. Policy & Regulatory Landscape
17. Import-Export Analysis
18. United Kingdom Economic Profile
19. Competitive Landscape
19.1. Chimerix UK Limited
19.2. SIGA Technologies, Inc.
19.3. Emergent BioSolutions UK Ltd.
19.4. Bavarian Nordic A/S
19.5. Mylan N.V.
19.6. Olon S.p.A.
19.7. Teva UK Limited
20. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security